In this study, we identified a novel candidate gene for ET, SLC38A6, via WES, WGS and Sanger sequencing of 71 families and 47 sporadic cases among 773 families and 640 sporadic cases diagnosed with ET, with a prevalence of approximately 8.35%. This evidence concerns the gene SLC38A6 and essential thrombocythemia.